Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.
about
Risk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivirDrug resistance in influenza A virus: the epidemiology and management.Influenza antivirals currently in late-phase clinical trial.Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals.Surveillance of antiviral resistance markers in Argentina: detection of E119V neuraminidase mutation in a post-treatment immunocompromised patient.H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016.Antigenic and genetic characterization of influenza viruses circulating in Bulgaria during the 2015/2016 seasonPaediatric Virology: A rapidly increasing educational challenge.Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.Combating mutations in genetic disease and drug resistance: understanding molecular mechanisms to guide drug design.Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection.Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study.Bax Inhibitor-1 Acts as an Anti-Influenza Factor by Inhibiting ROS Mediated Cell Death and Augmenting Heme-Oxygenase 1 Expression in Influenza Virus Infected Cells.An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017
P2860
Q28066861-364218F6-8D18-4E41-9C5C-177C549CC15DQ30234600-C35423E9-3857-42B8-90BE-3787B056E9AEQ30398099-21E49962-A8D0-4EC7-98F4-9AB2DBC4CF50Q30401424-A1D5A199-B40D-4AFF-8AB9-F269DA195527Q37487500-EE9CFBE1-3BC3-43FD-94A7-61E205234F81Q37677227-BF7165C2-9C35-4D7C-900B-60FFB9C10213Q37696769-6B40AAAD-3B74-4379-A5C4-AD8E80B4AD53Q37697706-7191C209-98DD-43BB-BC04-1571CDB76EF1Q38627487-372F3D2D-1BB6-42B6-A14F-C97EB68E56E8Q39296374-56A27D9E-8381-43CB-8A18-B7364366720BQ40094068-1593414B-FDC2-43B9-88FF-3982039E9D2FQ47555226-AF7F043F-DAD9-460D-A9FC-D1987953701AQ47562247-2FF93E8B-2C1E-482C-8914-215D551E627CQ51411108-21800D96-173D-4B97-AC94-CBA21395FB33Q53703982-63EF2651-17A8-43B1-91B5-65343607B816Q56969102-2400710C-BD6C-4457-9B0C-1DD7A7A48A6E
P2860
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Global update on the susceptib ...... inidase inhibitors, 2014-2015.
@en
Global update on the susceptib ...... inidase inhibitors, 2014-2015.
@nl
type
label
Global update on the susceptib ...... inidase inhibitors, 2014-2015.
@en
Global update on the susceptib ...... inidase inhibitors, 2014-2015.
@nl
prefLabel
Global update on the susceptib ...... inidase inhibitors, 2014-2015.
@en
Global update on the susceptib ...... inidase inhibitors, 2014-2015.
@nl
P2093
P2860
P50
P921
P1433
P1476
Global update on the susceptib ...... inidase inhibitors, 2014-2015.
@en
P2093
Adam Meijer
Angie Lackenby
Burcu Ermetal
Danielle Tilmanis
Dayan Wang
Dmitriy Pereyaslov
Emi Takashita
Ha T Nguyen
Marilda M Siqueira
P2860
P304
P356
10.1016/J.ANTIVIRAL.2016.06.001
P5008
P577
2016-06-02T00:00:00Z
2016-08-01T00:00:00Z